225 related articles for article (PubMed ID: 21041579)
1. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators.
Santangeli P; Di Biase L; Dello Russo A; Casella M; Bartoletti S; Santarelli P; Pelargonio G; Natale A
Ann Intern Med; 2010 Nov; 153(9):592-9. PubMed ID: 21041579
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of implantable cardioverter-defibrillators.
Sanders GD; Hlatky MA; Owens DK
N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
[TBL] [Abstract][Full Text] [Related]
4. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
[TBL] [Abstract][Full Text] [Related]
5. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
Peck KY; Lim YZ; Hopper I; Krum H
Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
Franqui-Rivera H; Sotomonte JC
P R Health Sci J; 2011 Jun; 30(2):78-83. PubMed ID: 21682151
[TBL] [Abstract][Full Text] [Related]
7. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
9. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
[TBL] [Abstract][Full Text] [Related]
10. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
Coats AJ
Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
[TBL] [Abstract][Full Text] [Related]
11. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
Nanthakumar K; Epstein AE; Kay GN; Plumb VJ; Lee DS
J Am Coll Cardiol; 2004 Dec; 44(11):2166-72. PubMed ID: 15582314
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
[TBL] [Abstract][Full Text] [Related]
14. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.
Katritsis DG; Siontis KC; Bigger JT; Kadish AH; Steinman R; Zareba W; Siontis GC; Bardy GH; Ioannidis JP
Heart Rhythm; 2013 Feb; 10(2):200-6. PubMed ID: 23107652
[TBL] [Abstract][Full Text] [Related]
15. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
Makki N; Swaminathan PD; Hanmer J; Olshansky B
Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Akel T; Lafferty J
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
[TBL] [Abstract][Full Text] [Related]
17. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in subgroups a systematic review.
Earley A; Persson R; Garlitski AC; Balk EM; Uhlig K
Ann Intern Med; 2014 Jan; 160(2):111-21. PubMed ID: 24592496
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT).
Dorian P; Hohnloser SH; Thorpe KE; Roberts RS; Kuck KH; Gent M; Connolly SJ
Circulation; 2010 Dec; 122(25):2645-52. PubMed ID: 21135366
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis.
Santangeli P; Pelargonio G; Dello Russo A; Casella M; Bisceglia C; Bartoletti S; Santarelli P; Di Biase L; Natale A
Heart Rhythm; 2010 Jul; 7(7):876-82. PubMed ID: 20380893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
